Bill Text: PA HB559 | 2009-2010 | Regular Session | Introduced

---

Bill Title: Further providing for Schedule I controlled substances.

Spectrum: Slight Partisan Bill (Republican 27-12)

Status: (Introduced - Dead) 2009-02-23 - Referred to JUDICIARY [HB559 Detail]

Download: Pennsylvania-2009-HB559-Introduced.html

---

PRINTER'S NO. 608
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 559 Session of2009
INTRODUCED BY BEYER, BEAR, BOYD, BRENNAN, ELLIS, FABRIZIO, FLECK, FRANKEL, GEIST, GILLESPIE, GINGRICH, GRELL, GROVE, HARKINS, HARPER, HENNESSEY, HORNAMAN, KAUFFMAN, KORTZ, LONGIETTI, MANN, MARSHALL, MILLARD, MILLER, MILNE, MURT, PASHINSKI, PYLE, REICHLEY, SABATINA, SAYLOR, SCAVELLO, SIPTROTH, K. SMITH, SWANGER, TRUE, VULAKOVICH AND WATSON, FEBRUARY 23, 2009
REFERRED TO COMMITTEE ON JUDICIARY, FEBRUARY 23, 2009
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
Schedule I controlled substances.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 4(1) of the act of April 14, 1972 (P.L.
233, No.64), known as The Controlled Substance, Drug, Device and
Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is
amended to read:
Section 4. Schedules of Controlled Substances.--The
following schedules include the controlled substances listed or
to be listed by whatever official name, common or usual name,
chemical name, or trade name designated.
(1) Schedule I--In determining that a substance comes within
this schedule, the secretary shall find: a high potential for
abuse, no currently accepted medical use in the United States,
and a lack of accepted safety for use under medical supervision.
The following controlled substances are included in this
schedule:
(i) Any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters, and ethers,
unless specifically excepted, whenever the existence of such
isomers, esters, ethers and salts is possible within the
specific chemical designation:
1. Acetylmethadol.
2. Allylprodine.
3. Alphacetylmethadol.
4. Alphameprodine.
5. Alphamethadol.
6. Benzethidine.
7. Betacetylmethadol.
8. Betameprodine.
9. Betamethadol.
10. Betaprodine.
11. Clonitazene.
12. Dextromoramide.
13. Dextrorphan (except its methylether).
14. Diampromide.
15. Diethylthiambutene.
16. Dimenoxadol.
17. Dimepheptanol.
18. Dimethylthiambutene.
20090HB0559PN0608 - 2 -
19. Dioxaphetyl butyrate.
20. Dipipanone.
21. Ethylmethylthiambutene.
22. Etonitazene.
23. Etoxeridine.
24. Furethidine.
25. Hydroxypethidine.
26. Ketobemidone.
27. Levomoramide.
28. Levophenacylmorphan.
29. Morpheridine.
30. Noracymethadol.
31. Norlevorphanol.
32. Normethadone.
33. Norpipanone.
34. Phenadoxone.
35. Phenampromide.
36. Phenomorphan.
37. Phenoperidine.
38. Piritramide.
39. Proheptazine.
40. Properidine.
41. Racemoramide.
42. Trimeperidine.
(ii) Any of the following opium derivatives, their salts,
isomers and salts of isomers, unless specifically excepted,
whenever the existence of such salts, isomers and salts of
isomers is possible within the specific chemical designation:
1. Acetorphine.
2. Acetyldihydrocodeine.
20090HB0559PN0608 - 3 -
3. Benzylmorphine.
4. Codeine methylbromide.
5. Codeine-N-Oxide.
6. Cyprenorphine.
7. Desomorphine.
8. Dihydromorphine.
9. Etorphine.
10. Heroin.
11. Hydromorphinol.
12. Methyldesorphine.
13. Methylhydromorphine.
14. Morphine methylbromide.
15. Morphine methylsulfonate.
16. Morphine-N-Oxide.
17. Myrophine.
18. Nicocodeine.
19. Nicomorphine.
20. Normorphine.
21. Pholcodine.
22. Thebacon.
(iii) Any material, compound, mixture, or preparation which
contains any quantity of the following hallucinogenic
substances, their salts, isomers, and salts of isomers, unless
specifically excepted, whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific
chemical designation:
1. 3,4-methylenedioxy amphetamine.
2. 5-methoxy-3,4-methylenedioxy amphetamine.
3. 3,4,5-trimethoxy amphetamine.
4. Bufotenine.
20090HB0559PN0608 - 4 -
5. Diethyltryptamine.
6. Dimethyltryptamine.
7. 4-methyl-2,5-dimethoxyamphetamine.
8. Ibogaine.
9. Lysergic acid diethylamide.
10. Mescaline.
11. Peyote.
12. N-ethyl-3-piperidyl benzilate.
13. N-methyl-3-piperidyl benzilate.
14. Psilocybin.
15. Psilocyn.
16. Tetrahydrocannabinols.
17. Salvia Divinorum.
(iv) Marihuana.
(v) Any material, compound, mixture or preparation which
contains any quantity of the following substances, including the
salts, isomers and salts of isomers:
1. Methaqualone.
(vi) Gamma hydroxybutyric acid, any salt, hydroxybutyric
compound, derivative or preparation of gamma hydroxybutyric
acid, including any isomers, esters and ethers and salts of
isomers, esters and ethers of gamma hydroxybutyric acid, except
gamma-butyrolactone (GBL), whenever the existence of such
isomers, esters and salts is possible within the specific
chemical designation. For purposes of security requirements
imposed by law or regulation upon registered distributors and
registered manufacturers, this substance when manufactured,
distributed or possessed in accordance with an exemption
approved under section 505(i) of the Federal Food, Drug, and
Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) shall,
20090HB0559PN0608 - 5 -
notwithstanding any other provision of this act, be classified
as a controlled substance in Schedule III of this section.
* * *
Section 2. This act shall take effect in 60 days.
20090HB0559PN0608 - 6 -